We tested three mAbs (clones A10, A11 and G7) for their binding strength and signaling inhibition in CRLF2-rearranged human BCP-ALL cell line (MUTZ5) and in Ba/F3-hTSLPR expressing cells. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.